Jan 11, 2026 12:00PM
Jan 5, 2026 06:00AM
Sep 3, 2025 06:57AM
May 6, 2025 06:05AM
Feb 13, 2025 06:05AM
Feb 10, 2025 06:02AM
Feb 10, 2025 06:00AM IDEAYA Biosciences Announces Appointment of Healthcare Investment Banking Veteran Joshua Bleharski as Chief Financial Officer
Jan 12, 2025 12:00PM
Jul 11, 2024 04:05PM
Jul 10, 2024 05:21AM
Jul 9, 2024 10:26PM
Jul 9, 2024 04:09PM
Jul 9, 2024 04:08PM
Jan 7, 2024 09:00AM IDEAYA Biosciences Announces Participation at the 42nd Annual J.P. Morgan Healthcare Conference and 2024 Corporate Guidance
Oct 27, 2023 04:02PM
Oct 25, 2023 05:37AM
Oct 24, 2023 10:15PM
Oct 24, 2023 04:08PM
Oct 24, 2023 04:07PM
Apr 27, 2023 04:01PM
Apr 25, 2023 05:20AM IDEAYA Biosciences (IDYA) Prices 7.44M Share Offering at $18.50/sh
Apr 25, 2023 12:15AM
Apr 24, 2023 04:13PM
Apr 24, 2023 04:12PM
Jan 9, 2023 06:01AM
Jan 9, 2023 06:00AM
Jan 3, 2023 06:00AM
Sep 19, 2022 04:01PM IDEAYA Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Sep 15, 2022 05:48AM
Sep 14, 2022 10:41PM
Sep 14, 2022 04:40PM
Sep 14, 2022 04:39PM
May 3, 2022 06:00AM
Jan 10, 2022 06:00AM
Aug 25, 2021 02:27PM Ideaya Biosciences (IDYA) PT Lowered to $31 at JPMorgan, After Model Update
Jul 12, 2021 04:11PM
Jul 7, 2021 09:29PM
Jul 6, 2021 04:01PM
Jul 6, 2021 04:01PM
May 6, 2021 06:00AM
Apr 16, 2021 11:02AM
Jan 11, 2021 06:07AM IDEAYA Biosciences (IDYA) Reports FDA Submission of IND Application for MAT2A Development Candidate IDE397 for Initiation of Phase 1
Jan 11, 2021 06:00AM
Jan 4, 2021 06:00AM
Aug 31, 2020 06:00AM
Jul 13, 2020 09:31AM
Jul 13, 2020 05:53AM
Jun 18, 2020 05:54AM
Jun 17, 2020 09:34PM IDEAYA Announces Pricing of Public Offering of Common Stock
Jun 16, 2020 04:01PM

276,561 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All